Back to mobile site

NewAmsterdam Pharma Co NV (NAMS) PT Lowered to $42 at RBC Capital

October 5, 2026 7:02 AM EDT Send to a Friend
(Updated - October 5, 2026 8:54 AM EDT)

RBC Capital analyst Leonid Timashev lowered the price target on NewAmsterdam ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login